News & Insights

GE HealthCare and Biofourmis collaboration supports the patient journey across the care continuum and eases transitions and care from the hospital to home

WellSpan Health, an eight-hospital integrated delivery system in Central Pennsylvania and Northern Maryland, has chosen Biofourmis to support the enterprise-wide expansion and management of a bundled program that includes hospital-level and post-acute care at home.

Biofourmis announces four new agreements with top pharmaceutical companies, driven by Biofourmis’ proven leadership and expertise in digital biomarker development and the strength of its comprehensive, device-and location-agnostic clinical trial solution.

Digital measures hold immense promise for revolutionizing drug development and advancing our understanding of treatment efficacy. Yet despite their transformative potential, their full utilization remains hindered by standardization hurdles, regulatory ambiguity, and limited awareness among patients and healthcare providers. Biofourmis and HealthXL recently set out to analyze the state of digital measures in drug development.

Biofourmis Expands Access to Care and Streamlines Workflows with Integrated On-Demand In-Home Services Ecosystem. Nursing, phlebotomy, infusion, durable medical equipment, imaging and other ancillary services easily ordered from curated network of service partners via Biofourmis platform.

Biofourmis, a leading global technology-enabled care delivery company, announced today that it has forged a new agreement with Nascentia Health, which offers a complete range of care management and insurance services that helps patients in Central New York receive the care they need at home.

An industry report released today forecasts that digital endpoints will see broader adoption in supporting pharmaceutical and life science label claims in the years ahead—but only after industry-wide, pre-competitive collaboration aimed at standardization and proactive sharing of data around clinically validated patient-centric outcomes.